At Computex 2025, we get a first look at Intel's new Battlemage-based workstation graphics cards, including a dual-GPU model ...

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.